Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fine

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Hospital & Community Psychiatry|April 1, 1989
Models of state funding for mental health researchT Fine, H A Pincus, R Ridge, et al.
Journal of Medical Economics|December 15, 2021
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trialJipan Xie, Yan Wang, Yaping Xu, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialNeil M Bressler, Tom S Chang, Jennifer T Fine, et al.
Biosensors & Bioelectronics|February 8, 2006
Luminescent yeast cells entrapped in hydrogels for estrogenic endocrine disrupting chemical biodetectionT Fine, P Leskinen, T Isobe, et al.
Pharmacoeconomics - Open|June 19, 2022
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM TrialMatthew Reaney, Prithvi Addepalli, Veleka Allen, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 14, 2007
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trialTom S Chang, Neil M Bressler, Jennifer T Fine, et al.
Clinical Therapeutics|December 16, 2021
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health BenefitNihar Desai, Jipan Xie, Yan Wang, et al.
JAMA|December 11, 1999
A prospective study of weight change and health-related quality of life in womenJ T Fine, G A Colditz, E H Coakley, et al.
Ophthalmology|March 2, 2010
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHORNeil M Bressler, Tom S Chang, Ivan J Suñer, et al.
Journal of Medical Economics|May 12, 2023
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United StatesSrihari S Naidu, Megan B Sutton, Wei Gao, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Hospital & Community Psychiatry|April 1, 1989
Models of state funding for mental health researchT Fine, H A Pincus, R Ridge, et al.
Journal of Medical Economics|December 15, 2021
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trialJipan Xie, Yan Wang, Yaping Xu, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2009
Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialNeil M Bressler, Tom S Chang, Jennifer T Fine, et al.
Biosensors & Bioelectronics|February 8, 2006
Luminescent yeast cells entrapped in hydrogels for estrogenic endocrine disrupting chemical biodetectionT Fine, P Leskinen, T Isobe, et al.
Pharmacoeconomics - Open|June 19, 2022
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM TrialMatthew Reaney, Prithvi Addepalli, Veleka Allen, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 14, 2007
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trialTom S Chang, Neil M Bressler, Jennifer T Fine, et al.
Clinical Therapeutics|December 16, 2021
Projecting the Long-term Clinical Value of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy in the United States: An Assessment of Net Health BenefitNihar Desai, Jipan Xie, Yan Wang, et al.
JAMA|December 11, 1999
A prospective study of weight change and health-related quality of life in womenJ T Fine, G A Colditz, E H Coakley, et al.
Ophthalmology|March 2, 2010
Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHORNeil M Bressler, Tom S Chang, Ivan J Suñer, et al.
Journal of Medical Economics|May 12, 2023
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United StatesSrihari S Naidu, Megan B Sutton, Wei Gao, et al.
Pageof 5